Roche’s ophthalmology drug Vabysmo (faricimab) has become the first product to be approved by the UK medicines regulator under the Access Consortium, an international work-sharing scheme that the agency joined post-Brexit to accelerate drug approvals.
The Medicines and Healthcare products Regulatory Agency joined the consortium in October 2020 to work with regulators from Australia, Canada,...